Navigation Links
General Data Acquires Triangle Biomedical Sciences

CINCINNATI, June 14, 2013 /PRNewswire-iReach/ -- General Data Company Inc., a leading manufacturer and provider of barcode identification, tracking and data management products and solutions, has announced that it has acquired Triangle Biomedical Sciences Inc., (TBS) of Durham, North Carolina, a leading manufacturer and supplier of instrumentation, reagents and consumables for the clinical and research pathology marketplace. TBS will become a division of General Data Healthcare, which provides specialty products and solutions to hospitals, independent labs and other healthcare facilities. With this acquisition, General Data Healthcare will now offer an expanded and comprehensive portfolio of equipment, solutions and supplies that enable histology laboratories to utilize advanced products and technologies for specimen identification, preparation, processing, tracking and storage.

Together, General Data and TBS have more than 35 years of experience producing innovative instrumentation and consumables for clinical and anatomic pathology laboratories. General Data introduced the first cassette labeler that utilizes laser-ablation technology, which has now become the global standard for effective and reliable barcode identification of tissue cassettes. TBS has one of the most comprehensive histology product lines in the industry, ranging from sophisticated microwave and conventional pressure vacuum tissue processing instrumentation to the highest quality consumables and reagents.

"General Data Healthcare is known worldwide as the leader for barcode identification and tracking in anatomic pathology laboratories," said Peter Wenzel, President and Chief Executive Officer of General Data. "The addition of TBS significantly broadens General Data Healthcare's product portfolio with very high quality instrumentation, reagents and consumables, as well as expands our team of product engineers and industry specialists. Together, we will offer a powerful combination of product, industry and user expertise that will be a significant benefit to our customers."

"The product and solutions offerings and technical capabilities of our two companies are very complementary," said Jack Hunnell, CEO and Chairman of the Board of TBS. "Bringing General Data Healthcare and TBS together will provide our customers with a range of truly innovative products that labs can utilize to improve their processes and provide superior patient care."

Financial details have not been disclosed. Both companies are privately held.

About General Data Healthcare
General Data Healthcare Inc., a subsidiary of General Data Company Inc., ( is a leading innovator and provider of labeling, identification and tracking solutions for healthcare facilities. General Data Healthcare's products and solutions enable healthcare facilities to improve efficiencies, eliminate errors and enhance patient safety through reliable and cost-effective technology solutions that deliver true value while enabling staff to focus on what they do best: patient safety and services. General Data Healthcare's ID/Positive® laboratory specimen identification and tracking solutions are used in histology labs worldwide to automate, streamline, error-proof and optimize specimen processing and lab workflow. For more information, visit, or email

About Triangle Biomedical Sciences, Inc.
Founded in 1984 in Durham, NC, Triangle Biomedical Sciences, Inc. ( has grown from producing disposable microtome blades and blade holders to providing one of the most comprehensive lines of innovative histology equipment, apparatus, reagents and supplies in the industry. TBS continues to be headquartered in Durham, and serves the histology lab market with products that are uniquely designed to maximize performance and productivity.

About General Data Company, Inc. 
General Data Company, Inc. is recognized as a premier provider of innovative barcode identification and automated data collection products, solutions and services that enable organizations to streamline workflow, error proof processes, better manage critical data, and improve business-process accuracy, productivity and performance. Founded in 1981, General Data is a privately held company with headquarters in Cincinnati, Ohio USA. More information on General Data's products and solutions can be found at

Media Contact:  Media Relations General Data Company, Inc., 800-733-5252 ext.6473,

News distributed by PR Newswire iReach:

SOURCE General Data Company, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
2. 3SBio Inc. Announces Receipt of Amended "Going Private" Proposal at $16.70 Per ADS and Intent to Adjourn Extraordinary General Meeting of Shareholders
3. IDEXX Laboratories Names Jeffrey Fiarman Executive Vice President and General Counsel
4. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
5. NJBIZ Honors New Jerseys General Counsels
6. PDP Holdings, LLC Announces Support for Health and Human Services Office of Inspector General Guidance
7. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
8. 3SBio Inc. Announces Extraordinary General Meeting of Shareholders
9. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
10. Class III Obese Patients Experience Adverse Events More Frequently Than the General Adverse Event Patient Population
11. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
Post Your Comments:
(Date:12/1/2015)... Dec. 1, 2015  Six months of adjunctive metformin therapy ... 1 diabetes, according to new research from T1D Exchange ... may have a beneficial effect on measures of obesity, including ... of the Journal of the American Medical Association , ... effect of metformin on overweight and obese adolescents with type ...
(Date:12/1/2015)... 1, 2015 During the recent 2015 ... San Francisco, CA , Medinol Ltd. continued ... marketplace. During a satellite symposium, "The BioNIR eDES: ... Minimize Restenosis", a renowned physician panel discussed the ... CoCr Coronary Stent System and the Medinol eDES ...
(Date:12/1/2015)... Russia has always been a country of choice for ... Europe in 2015 were tested in phase II-III ... has always been a country of choice for global multi-center phase ... in 2015 were tested in phase II-III clinical trials ... always been a country of choice for global multi-center phase III clinical ...
Breaking Medicine Technology:
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... It’s ... has a tattoo — a number even greater among Millennials (a whopping one in ... are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... 01, 2015 , ... The importance of volumetric breast density ... of numerous abstracts accepted for presentation here, at the 101st Annual Radiology Society ... the use of Volpara Solutions’ quantitative breast imaging software tools for providing breast ...
(Date:12/1/2015)... Diego, CA (PRWEB) , ... December 01, 2015 ... ... and scale , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro ... mobile imaging results enhancements at the Radiological Society of North America (RSNA) 2015 ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... it has been awarded a fixed price per sprint agile development contract to ... at $34 million over five years, provides software engineering, infrastructure, as well as ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):